Pre-market · Regular session opens 9:30 AM ET
Last update: Aug 11, 2026, 6:28 PM ET
Cardinal Health, Inc.
$240.26 1.30% today
Pre-market

Why Cardinal Health, Inc. (CAH) stock moved

Updated Aug 12, 2026

Cardinal Health, Inc. (CAH) shares rose 1.3% to $240.26 as of August 12, 2026, a modest gain from the prior close of $237.18. BestStocks flagged the session as a major change for CAH. The move is tied to an earnings beat. Below, we break down what changed for CAH, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

Earnings Beat

Cardinal Health, Inc. (CAH) reported EPS of $2.91 vs. consensus estimate of $2.42, beating consensus by 20.2%. Monitor CAH's next quarterly earnings report and any management guidance updates for confirmation of sustained earnings momentum.

This summary describes the catalyst and move as first detected on Aug 11, 2026, 10:20 AM EDT; the stock has continued trading since, so the current price and percentage move (shown above) may be larger or smaller than the figures here.
Material / EarningsLow confidence
Rel. volume
1.2×
Normal
Vs peers
No comparable peers
Market cap
$56.3B
New York Stock Exchange
Analyst target
$262
+9.2% vs price
Price chart
Aug 12
Not enough price data.
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Cardinal Health, Inc. investors

For Cardinal Health, Inc. investors, the balance of recent signals points to a bullish shift. On the constructive side: Earnings beat with positive market reaction; Positive 1.3% session move. Weighing against that: New SEC filing — review for material disclosures; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $262.40, implying +9.2% upside from $240.26. BestStocks rates the overall signal quality low (56/100).

CAH price reaction

CAH last traded at $240.26, up $3.08 (+1.30%) from the previous close of $237.18. The session traded on 1.2× average volume (normal), so participation was unremarkable.

Bullish and bearish analyst opinions on Cardinal Health, Inc. (CAH)

Latest catalyststrengthens the bull case
The latest catalyst — an earnings beat the market rewarded — it strengthens the bull case and confirms the prevailing bullish analyst lean.

The consensus analyst price target on Cardinal Health, Inc. (CAH) is $262.40, 9.2% above the recent $240.26. Over the past 90 days analysts logged 0 upgrades, 5 maintains, and 0 downgrades. Here is how the bullish and bearish cases on CAH line up.

The bullish case

  • Wall Street's consensus price target of $262.40 implies +9.2% upside from $240.26.
  • The Street's most bullish target is $292.00 (+21.5%).
  • Earnings beat with positive market reaction.
  • Positive 1.3% session move.
  • Positive price momentum.

The bearish case

  • The most bearish analyst target is $240.00 (-0.1%).
  • Cardinal Health, Inc. (CAH) moved -2.88% from $227.09 to $220.54 on 2026-07-22.
Bull vs bear balanceBullish Shift
BearishNeutralBullish
The latest catalyst moved the balance toward the bulls — the hollow tick marks where it sat before.

Weighing both sides, BestStocks' composite read of recent signals is bullish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Aug 12, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $262+9.2%
= 5 maintains
Citigroup maintained Buy · 2026-07-24
SEC filings watch
10-K2026-08-11
Annual financial report
high
8-K2026-08-11
Material event — review for impact
high
8-K2026-08-11
Material event — review for impact
high
8-K2026-08-05
Material event — review for impact
high
Peer context
CAH+1.3%

Previous notable changes for CAH

Filings2026-08-11
Cardinal Health, Inc. (CAH) filed an 8-K on August 11, 2026. The audit found only the filing date; no details about the content or reason for the filing were available.
Valuation2026-08-11via Yahoo Finance
Cardinal Health reported fiscal Q4 2026 adjusted EPS of $2.91, beating consensus of $2.42, and provided FY2027 guidance of $12.40–$12.60 (13–15% growth), per the company's earnings release on PRNewswire. The stock rose 2.87% to $243.99, though revenue of $63.7 billion slightly missed Wall Street forecasts.
Material / Earnings2026-08-11
Cardinal Health, Inc. (CAH) moved -1.13% from $243.00 to $240.26 on 2026-08-11, the same day the company reported EPS of $2.91 versus consensus estimate of $2.42, a +20.25% beat.
Material / Earnings2026-08-06
CAH moved -2.60% from its $244.01 open to a $237.66 close on 2026-08-06.
Upcoming catalysts & outlook
Next earnings
Unknown
10-K Annual Report (est.)
2027-08-11
Medium impact
Thesis shift
Bullish Shift
bullish signal
Risk level
Low
from change events

Frequently asked questions about CAH

Why did Cardinal Health, Inc. (CAH) stock move?

CAH rose 1.3% to $240.26. The move is associated with an earnings beat.

How much did CAH stock rise?

CAH gained 1.30% ($3.08) versus the prior close of $237.18, last trading at $240.26 on 1.2× average volume.

What is the analyst price target for CAH?

The consensus analyst price target for CAH is $262.40, about 9.2% above the current $240.26. Over the past 90 days, analysts recorded 0 upgrades, 5 maintains, and 0 downgrades.

How BestStocks tracks CAH

This page is generated automatically by BestStocks' change-detection system after an earnings beat was detected and verified against independent data sources. It draws on 12 tracked change events for CAH, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of August 12, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataFMP earnings & estimatesSEC EDGAR filingsAnalyst ratings & price targets (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.